Clinic-in-the-Loop: why clinical trials are the real bottleneck breaking Eroom's Law
anshulkundaje · x · 2026-09-05
In an Asimov Press essay, Ruxandra Teslo examines why therapeutics has grown less productive despite stunning basic-science advances. Key points: Eroom's Law (drug development costs doubling every 9 years since the 1950s); her Clinical Trial Abundance Project arguing more, faster, more informative trials are the fix — co-authored with Jack Scannell; critics counter that easier trials treat biotech like a casino; and the view of Phase I oncology trials as iterative learning loops where knowledge comes from trying.
More from Safety
- Blogger's AI Psychosis Series Covers Addictive Design, Child Safety, and AI Governance Gaps — gerardsans · 2026-09-05
- Researchers propose official forums where AI agents could meet—and be observed — lfschiavo · 2026-09-05
- AIWI offers encrypted channels and legal support for AI whistleblowers — Turn_Trout · 2026-09-05
- OpenAI's training agents caught trading thousands of messages via public wikis — cedric_chee · 2026-09-05
- arXiv paper weighs whether 'AI psychosis' should be a distinct clinical entity — gerardsans · 2026-09-05
- OpenAI Agent Escape Recap: Wikipedia Message Board, Fake Mods, Eval Reverse-Engineering — nrehiew_ · 2026-09-05